Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
M Megna, E Camela, T Battista, L Genco… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The management of moderate-to-severe forms of psoriasis is becoming a
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
Treating psoriasis in the elderly: biologics and small molecules
M Megna, L Potestio, G Fabbrocini… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Psoriasis prevalence in the elderly is growing. It is estimated that 15% of elderly
psoriasis patients suffer from moderate-to-severe disease, thus requiring systemic …
psoriasis patients suffer from moderate-to-severe disease, thus requiring systemic …
Biological treatments for pediatric psoriasis: state of the art and future perspectives
F Diotallevi, O Simonetti, G Rizzetto, E Molinelli… - International Journal of …, 2022 - mdpi.com
Psoriasis is a chronic systemic inflammatory disease that primarily affects the skin and is
associated with multiple comorbidities with a considerable reduction in quality of life of …
associated with multiple comorbidities with a considerable reduction in quality of life of …
Cardiometabolic comorbidities in patients with psoriasis: focusing on risk, biological therapy, and pathogenesis
J Cai, L Cui, Y Wang, Y Li, X Zhang… - Frontiers in Pharmacology, 2021 - frontiersin.org
Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques,
accompanied by systemic damage that leads to the development of multiple comorbidities …
accompanied by systemic damage that leads to the development of multiple comorbidities …
Durability and long-term outcomes of biologic therapies in psoriasis
Introduction Significant advances in psoriasis treatment have taken place since the
introduction of biologics. Tumor necrosis factor inhibitors were the first class of biologics …
introduction of biologics. Tumor necrosis factor inhibitors were the first class of biologics …
Salvianolic acid B in microemulsion formulation provided sufficient hydration for dry skin and ameliorated the severity of imiquimod-induced psoriasis-like dermatitis in …
JW Guo, YP Cheng, CY Liu, HY Thong, CJ Huang… - Pharmaceutics, 2020 - mdpi.com
Psoriasis is a chronic inflammatory skin disorder with a pathogenesis involving the
interleukin-23/interleukin-17 axis. Salvianolic acid B exerts several pharmacological effects …
interleukin-23/interleukin-17 axis. Salvianolic acid B exerts several pharmacological effects …
[HTML][HTML] Active implications for dermatologists in 'SARS‐CoV‐2 ERA': personal experience and review of literature
A Campanati, V Brisigotti, F Diotallevi… - Journal of the …, 2020 - ncbi.nlm.nih.gov
On 31 December 2019 from the Chinese city of Wuhan, Hubei, comes the first case of
'atypical ARDS/interstitial pneumonia'. On 11 February 2020, the WHO officially announced …
'atypical ARDS/interstitial pneumonia'. On 11 February 2020, the WHO officially announced …
Vaccines against SARS-CoV-2 in psoriasis patients on immunosuppressive therapy: Implications of vaccination nationwide campaign on clinical practice in Italy
F Diotallevi, A Campanati, G Radi, E Martina… - Dermatology and …, 2021 - Springer
More than 12 months have passed since the World Health Organization (WHO) declared
Coronavirus Disease 19 (COVID-19), caused by the SARS-CoV2 virus, to be a pandemic on …
Coronavirus Disease 19 (COVID-19), caused by the SARS-CoV2 virus, to be a pandemic on …
Psoriasis comorbidity management in the COVID era: a pressing challenge
Y Song, L Yao, S Li, J Zhou - Frontiers in Microbiology, 2023 - frontiersin.org
The global COVID-19 pandemic has presented a significant, ongoing challenge since its
emergence in late 2019. Today, the Omicron strain, which is less lethal but more contagious …
emergence in late 2019. Today, the Omicron strain, which is less lethal but more contagious …
Identification of a type II LacNAc specific binding lectin CMRBL from Cordyceps militaris
X Liu, Z Yang, C Liu, B Xu, X Wang, Y Li, J Xia… - International Journal of …, 2023 - Elsevier
The Cordyceps militaris gene CCM_03832 encodes a ricin-B like lectin. The gene was
cloned and expressed in Escherichia coli, and its protein product, named CMRBL (C …
cloned and expressed in Escherichia coli, and its protein product, named CMRBL (C …